BetterLife Pharma Inc. SEC filings BETRF
BetterLife Pharma Inc. has 244 filings in SEC EDGAR's recent list, going back to Aug 7, 2009. Its latest annual report, Form 20-F, was filed on Jun 1, 2026 for the period ended Jan 31, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 17, 2019, covering the quarter ended Apr 30, 2019. The most recent current report (Form 6-K) was filed on Sep 30, 2026. The company's fiscal year ends on January 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 20-F | Filing | Jun 1, 2022 | Jan 31, 2022 |
| NT 20-F | Filing | Jun 1, 2020 | Jan 31, 2020 |
| NT 10-Q | Filing | Jun 17, 2019 | Apr 30, 2019 |
| NT 10-K | Filing | Apr 30, 2019 | Jan 31, 2019 |
| NT 10-Q | Filing | Dec 18, 2018 | Oct 31, 2018 |
| NT 10-Q | Filing | Jun 15, 2018 | Apr 30, 2018 |
| NT 10-Q | Filing | Sep 15, 2017 | Jul 31, 2017 |
| D | Filing | Dec 8, 2015 | — |
| NT 10-Q | Filing | Jun 16, 2015 | Apr 30, 2015 |
| NT 10-K | Filing | May 4, 2015 | Jan 31, 2015 |
| DEFR14A | Schedule 14a | Aug 27, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2014 | — |
| DEFR14A | Schedule 14a | Aug 20, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2014 | — |
| NT 10-K | Form 10-k | May 2, 2014 | Jan 31, 2014 |
| UPLOAD | Letter from the SEC | Apr 10, 2014 | — |
| CORRESP | Letter to the SEC | Apr 9, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2014 | — |
| NT 10-Q | Form 12b-25 | Jun 14, 2013 | Apr 30, 2013 |
| NT 10-K | Filing | May 2, 2013 | Jan 31, 2013 |
| NT 10-K | Notification of late filing | May 1, 2012 | Jan 31, 2012 |
| NT 10-K | Notification of late filing | May 3, 2011 | Jan 31, 2011 |
| NT 10-Q | Notice of late filing | Jun 15, 2010 | Apr 30, 2010 |
| NT 10-K | Notification of late filing | May 4, 2010 | Jan 31, 2010 |
| EFFECT | Filing | Mar 18, 2010 | — |
| CORRESP | Letter to the SEC | Mar 16, 2010 | — |
| CORRESP | Letter to the SEC | Mar 16, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2010 | — |
| CORRESP | Letter to the SEC | Mar 4, 2010 | — |
| UPLOAD | Letter from the SEC | Dec 29, 2009 | — |
| CORRESP | Letter to the SEC | Dec 3, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2009 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BETRF (OTC)
- Fiscal year ends
- January 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1464165
- Former names
- Pivot Pharmaceuticals Inc. (until Dec 3, 2019); Neurokine Pharmaceuticals Inc. (until Mar 26, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.